Anxiety Disorder: Symptoms, Causes and Treatment

Anxiety disorder is when a person feels intense worry or fear in everyday situations and it affects over 40 million adults in the United States annually, according to the Anxiety and Depression Association of America (2022). 

These mental disorders manifest through various symptoms that significantly disrupt daily life. These symptoms profoundly weigh upon a person’s emotional, cognitive, and physical well-being, culminating in what is termed a mental health crisis. The “State of Mental Health in America” report by Mental Health America (2020) recounts that nearly one in five people in the U.S., or 47.1 million individuals, are in a mental health crisis, marking an increase of approximately 1.5 million from 2019’s figure.

Categories of anxiety disorder symptoms are emotional such as a persistent feeling of worry, fear, and anger, cognitive symptoms like difficulty concentrating, and physical symptoms often presenting as fatigue and muscle tension. The Anxiety and Depression Association of America (2022) notes that nearly 20% of adults experience these symptoms each year, spotlighting the widespread impact of these conditions.

Anxiety disorders, including generalized anxiety disorder, panic disorder, social anxiety disorder, and specific phobias, require a multifaceted approach to treatment. According to the National Institute of Mental Health (2022), a combination of therapy, medication, and lifestyle adjustments is essential for the successful management of these anxiety disorders. As such, collaborative care requiring clinical psychologists, psychiatrists, and primary care providers massively ameliorates outcomes, aiding individuals to regain their quality of life.

What Is Anxiety Disorder?

Anxiety Disorder is a mental health condition characterized by excessive and persistent worry, fear, or nervousness that interferes with daily life. This disorder affects how individuals think, feel, and behave, leading to significant distress or impairment in social, occupational, or other important areas of functioning. Common manifestations of anxiety disorders include panic attacks, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), and specific phobias.

The most common type of anxiety disorder is Generalized Anxiety Disorder (GAD). GAD is expressed in persistent and excessive worry about various aspects of daily life, such as health, work, and social interactions. Generalized Anxiety Disorder (GAD) affects 6.8 million adults, or 3.1% of the U.S. population, with only 43.2% receiving treatment, and women are twice as likely to be affected as men, with GAD transpiring alongside major depression as mentioned by the Anxiety and Depression Association of America’s (2022) article “Anxiety Disorders – Facts & Statistics.”

According to the Anxiety and Depression Association of America‘s (2022), “Anxiety Disorders – Facts & Statistics,” around 40 million (19.1%) adults in the U.S. are diagnosed with an anxiety disorder each year. Yet, only about 36.9% of those affected receive treatment.

As noted in the “State of Mental Health in America” report by Mental Health America (2020), nearly one in five individuals in the U.S., or 47.1 million people, live with a mental health condition, an increase of about 1.5 million from the previous year.

The “State of Mental Health” report also adds that among U.S. youth, around 10% experience severe depression, with the highest rates observed among those identifying as more than one race (12%). Despite these figures, 57% of adults and 60% of youths with mental illness do not receive treatment. Utah was recounted as having the poorest overall adult mental health, while Hawaii was ranked the best. Additionally, about 8% of Americans struggle with substance abuse disorders, with the District of Columbia showing the highest rates (13%) and Texas the lowest (6.3%). 

Moreover, the report reveals that nearly 11 million people had serious thoughts of suicide, marking an increase of 460,000 from the previous year. Utah had the highest percentage of adults with suicidal thoughts, and New Jersey had the lowest. Furthermore, the proportion of people with a mental illness who are uninsured rose to nearly 11%, the first increase since the Affordable Care Act was enacted, reflecting the impact of the Trump administration then.

What Are the Symptoms of Anxiety Disorder?

The symptoms of anxiety disorder are excessive worry, restlessness, and panic attacks. Those experiencing anxiety grapple with a pervasive sense of uneasiness and fear, which can lead to physical symptoms and behavioral changes as listed by the Anxiety and Depression Association of America’s (2022) article “Anxiety Disorders – Facts & Statistics.”. While the intensity and mingling of symptoms vary from person to person, the feelings associated with anxiety are devastating, resembling a constant state of stress or panic. The most common and severe symptoms of anxiety disorder are given below as discussed in Cleveland Clinic’s (2024) article “Overview-What is an anxiety disorder?”:

• Panic Attacks: Panic attacks, engendered by anxiety disorder, are sudden and intense episodes of fear that trigger severe physical symptoms such as heart palpitations, chest pain, and shortness of breath. These attacks occur without apparent reason, spawning substantial distress and disruption in everyday living. Panic disorder affects 6 million adults or 2.7% of the U.S. population. Women are twice as likely to be affected as men (Anxiety and Depression Association of America, 2022).
• Restlessness: Restlessness, as a symptom of anxiety disorder, involves a constant state of agitation and the inability to relax. This sharp unease creates chronic fatigue and difficulty concentrating, making everyday tasks challenging. Generalized Anxiety Disorder (GAD), which includes restlessness as a symptom, affects 6.8 million adults or 3.1% of the U.S. population (Anxiety and Depression Association of America, 2022).
• Fear: Fear, within the framework of anxiety disorder, refers to irrational and persistent dread of situations or objects that pose little or no real danger. This overwhelming fear drives individuals to abscond certain activities or social interactions, severely restricting their daily lives. Specific phobias affect 19.3 million adults, accounting for 9.1% of the U.S. population  (Anxiety and Depression Association of America, 2022).
• Uneasiness: Uneasiness in anxiety disorder is signalized by a pervasive sense of dread or apprehension that lingers throughout the day. This feeling interferes with normal activities, bringing to a constant state of discomfort and worry. Individuals with anxiety disorders often report a pervasive sense of unease, which is a common symptom of GAD. The prevalence of GAD is 3.1% of the U.S. population, indicating that many individuals experience chronic uneasiness as part of their anxiety (Anxiety and Depression Association of America, 2022).
• Stress: Stress, as experienced in anxiety disorder, is not just a reaction to external pressures but an ongoing state of magnified tension. These long-time stress sequels to physical symptoms such as headaches and muscle tightness, further intensifying the anxiety and making it harder to manage. 

Despite several years of adjusting to a new reality and the societal upheaval brought on by the COVID-19 pandemic, Americans continue to struggle with its disruptions. According to the American Psychological Association (2020) report, “STRESS IN AMERICA™ 2020: A National Mental Health Crisis,” nearly 8 in 10 adults (78%) report that the pandemic is a significant source of stress in their lives, and 2 in 3 adults (67%) say they have experienced increased stress during the pandemic (Anxiety and Depression Association of America, 2022).

• Cognitive Disruptions: Cognitive disruptions, brought about by anxiety disorder, are difficulties with concentration, memory lapses, and a continual stream of worrisome thoughts. These interruptions hinder performance at work or school and create major challenges in normal functioning. Cognitive disruptions, such as difficulty concentrating and memory lapses, are symptoms of GAD, which affects 3.1% of the U.S. population  (Anxiety and Depression Association of America, 2022).
• Behavioral Changes: Behavioral changes, driven by an anxiety disorder, manifest as evasion of situations that provoke anxiety, social withdrawal, and increased irritability. These alterations spark a vicious cycle, where anxiety symptoms become worse due to these behavioral adaptations. 

As revealed by Credit Karma (2023) report, “Forget doom scrolling, Americans now doom spend to cope with stress,” 35% of Gen Z engage in doom spending, a behavior confirmed by their survey, where 41% of Gen Z respondents admitted to this practice. Over a quarter of Americans (27%) use doom spending as a way to cope with stress, but among Gen Z, only 18% reported that it made them feel better. Additionally, 75% of Gen Z respondents expressed concern or tremendous concern about the prevailing economic situation. As highlighted in the “STRESS IN AMERICA™ 2020: A National Mental Health Crisis” report, half of Gen Z teens (51%) feel that the coronavirus pandemic made planning for their future seem impossible, with more than two-thirds of Gen Z adults in college (67%) sharing the same sentiment.

During an anxiety attack, individuals experience an amalgamation of physical and cognitive symptoms. Physical symptoms are rapid heartbeat, sweating, trembling, and shortness of breath. Cognitively, individuals describe feelings of impending doom, fear of losing control, and racing thoughts.

What Are the Symptoms of Anxiety Disorder in Females?

Symptoms of anxiety disorder in females represent the emotional, physical, and behavioral indicators of intense worry, fear, or unease, significantly affecting quotidian routines and functioning. 

The most severe symptoms of anxiety disorder in females as considered by the FDA Office Of Women’s Health (2023) article “Women and Anxiety” are panic attacks, avoidance behavior, depersonalization, and intrusive thoughts. Panic attacks are sudden, intense episodes of fear accompanied by physical symptoms. Avoidance behavior is actively steering clear of situations that trigger their anxiety. Depersonalization occurs in females when they perceive detachment from themselves or their surroundings. In addition, intrusive thoughts—unwanted and distressing ideas that are difficult to control—further exacerbate the anxiety experience. In addition, intrusive thoughts—unwanted and distressing ideas that are difficult to control—further exacerbate the anxiety experience.

As explained by the National Center for Health Statistics’s (2013) “National Health Interview Survey,” women were more likely than men to experience anxiety symptoms across all severity levels. Specifically, 11.3% of women reported mild symptoms contrasted with 7.6% of men, 4.3% of women experienced moderate symptoms versus 2.4% of men, and 3.5% of women had severe symptoms as opposed to 1.9% of men. Overall, 19.0% of women experienced anxiety symptoms of any severity in the past two weeks, contrary to 11.9% of men.

The symptoms of anxiety disorder in females create a whirlwind of overwhelming emotions, leaving individuals feeling trapped in a cycle of fear and uncertainty. These experiences precipitate a profound sense of disconnection from oneself and the world, making mundane life appear daunting and unmanageable. 

What Are the Symptoms of Anxiety Disorder in Children?

Symptoms of anxiety disorder in children are signs that signal immoderate fear, worry, or nervousness that muddles their day-to-day activities. Children with anxiety disorder exhibit unique symptoms that differ from those in adults. 

The most common symptoms in children are separation anxiety and specific phobias while social anxiety and generalized anxiety disorder become more prevalent in adolescence. 

Key symptoms in children are excessive clinginess to parents or caregivers, frequent complaints of stomach aches or headaches, refusal to attend school, and difficulty sleeping alone. Children also display irritability, restlessness, and difficulty concentrating in academic settings. Anxiety in children manifests as behavioral issues, such as tantrums or defiance, particularly when faced with anxiety-provoking situations.

As indicated in a published research by Feriante, Joshua, et al. (2023) in the National Library of Medicine’s National Center for Biotechnology Information titled “Separation Anxiety Disorder,” anxiety disorders are among the most prevalent pediatric mental health issues, with an estimated global prevalence ranging from 5% to 25%. 

Separation Anxiety Disorder (SAD) is the most frequently diagnosed childhood anxiety disorder, accounting for 50% of anxiety-related mental health treatment referrals. Population-based studies estimate the prevalence of SAD at 4%, increasing to 7.6% in pediatric clinical samples. 

Clinical data, the report further records, shows that 4.1% of children will experience a clinical level of separation anxiety, with about one-third continuing to struggle into adulthood if left untreated. The average age of onset is around 6 years, making it one of the earliest anxiety disorders to manifest in children. 

In a U.S.-based study by Kessler, R. C., et al. (2012), “Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States,” SAD is posited to have the highest lifetime prevalence, at 6.7%, of all anxiety disorders when specific and social phobias are excluded. The lifetime prevalence of adult SAD is 6.6%, with 77.5% of those affected reporting onset in adulthood.

What Are the Symptoms of Anxiety Disorder in Dogs?

Symptoms of anxiety disorder in dogs are behavioral and physical signs that reveal a state of unrestrained fear, edginess, or stress, disrupting their normal activities and welfare.

Mood, Abbie (2024), staff writer at the American Kennel Club Canine Health Foundation explains in the article “How to Tell If Your Dog Is Stressed,” that common symptoms of anxiety in dogs consist of excessive barking or howling, destructive behavior, pacing, trembling, and attempting to escape. Dogs with anxiety exhibit excessive panting, drooling, or salivation even in the absence of physical exertion. They display avoidance behaviors, such as hiding or cowering, when faced with anxiety-triggering stimuli. Physical symptoms involve loss of appetite, gastrointestinal issues, and excessive shedding. In severe cases, dogs become aggressive or develop compulsive behaviors like excessive licking or chewing.

Kriss, Randa (2024) states in the blog post “Anxiety in Dogs: Signs, Symptoms, Treatment” on the American Kennel Club website, that roughly 14% of dogs are estimated to suffer from separation anxiety, which is conspicuous when dogs become distressed when left alone or separated from their owners.

What Are the Causes of Anxiety Disorder?

The causes of anxiety disorder are genetics, brain chemistry, and environmental factors. The risk of developing an anxiety disorder is influenced by genetic and environmental factors, with specific risk factors varying by the type of anxiety disorder. The most common primary causes of anxiety disorder, as discussed by the National Institute of Mental Health (2024) in the article “What is Anxiety?” are as follows:

• Genetics: Genetics, the inherited biological traits from parents, heightens the likelihood of developing anxiety disorders when there is a family history due to the transmission of anxiety-related genes. As reported by Hae-Ran, Na, et al. (2011) in “The Genetic Basis of Panic Disorder,” published in the Journal of Korean Medical Science, six controlled family studies have documented an increased risk of Panic Attack Disorder (5.7%-17.3%) among the relatives of affected individuals.
• Brain Chemistry: Brain chemistry, as a consequence of a chemical imbalance in neurotransmitters like serotonin and norepinephrine, disrupts normal brain function, setting the pace for the springing up of anxiety disorders. 

In a study by Burke, Shanna L., et al. (2024) titled “Examining the relationship between anxiety and regional brain volumes in the National Alzheimer’s Coordinating Center uniform, imaging, and biomarker datasets,” involving 1,533 participants, it was found that anxiety in the brain is linked to enormous atrophy in multiple brain regions. Specifically, seven MRI regions exhibited lower volumes in individuals with anxiety, which are the total cerebrum gray matter, right hippocampus, right and left frontal lobe cortical gray matter, and right and total temporal lobe cortical gray matter.

• Environmental Factors: Environmental factors, such as trauma, childhood sexual abuse, prolonged stress, or considerable life changes, trigger or intensify anxiety disorders by creating staggering or destabilizing conditions. In SingleCare’s (2020) anxiety survey, nearly 48% of respondents reported that stress at home was the cause of their anxiety, while 30% reported workplace stress.
• Medical Conditions: Medical conditions, such as thyroid disorders or chest pain from heart disease, expand the risk of anxiety disorders by placing more strain on the body and mind, exacerbating anxiety symptoms. Data from the “Medical Expenditure Panel Survey” (2007, 2009) in the United States reported that 10.5% of adults with anxiety (without depression) had comorbid heart disease.
• Substance Use: Substance use, concerned with the intake or withdrawal from substances like alcohol, caffeine, or drugs, worsens anxiety symptoms by altering brain chemistry and disrupting emotional stability. Conflict and insomnia also contribute to the rise or amplification of anxiety disorders. Furthermore, depression and symptoms like obsessive-compulsive disorder (OCD) or post-traumatic stress disorder (PTSD) are observed in individuals with anxiety disorders, thus continuously weighing upon their holistic health. The “United States National Survey on Drug Use and Health” (2022) reports that 21.5 million American adults, representing 8.4% of the population, experienced both a mental health disorder and a substance use disorder, known as co-occurring disorders, in the past year.

What Are the Treatments for Anxiety Disorder?

The treatments for anxiety disorder include counseling, medications, and lifestyle changes. Cognitive Behavioral Therapy (CBT) and other counseling approaches support individuals in identifying and managing negative thought patterns, providing effective coping strategies. Medications, such as antidepressants, are prescribed to balance brain chemicals and alleviate symptoms. Incorporating regular exercise, stress management approaches, and a healthy diet encourages general mental well-being and lessens anxiety symptoms. The most common treatments for anxiety disorder are categorized below as proferred by the National Institute of Mental Health (2024) in the article “What is Anxiety?”:

Self-care

Self-care, from an anxiety disorder perspective, is taking proactive steps to maintain and upgrade one’s physical, mental, and emotional well-being. Self-care empowers individuals to manage symptoms through healthy lifestyle choices and stress-reduction strategies. The most important activities of sef-care are given below as explained by Kabrick, Siri (2024) in the Mayo Clinic Health System blog piece, “11 tips for coping with an anxiety disorder”:

• Avoid Alcohol: Avoiding alcohol prevents interference with brain chemistry; hence the germination of anxiety symptoms, making abstinence a mood stabilizer. In their systematic review titled “Harm Reduction: A Systematic Review on Effects of Alcohol Reduction on Physical and Mental Symptoms,” Charlet and Heinz (2016) evaluated the impact of reducing alcohol consumption on physical and mental health. The duo analyzed 63 studies and found that interventions aimed at reducing alcohol intake, including abstinence, led to significant health benefits. These benefits included reductions in alcohol-related injuries, improved heart function, lower blood pressure, better liver health, and lessened psychiatric symptoms. Additionally, alcohol reduction resulted in improved quality of life, lower psychosocial stress, and notable socioeconomic benefits. The review highlights the importance of early screening and intervention for problematic alcohol use in healthcare settings.
• Quit Smoking: Quitting smoking is the complete cessation of tobacco products, which is particularly important for individuals with anxiety disorder. Nicotine, a stimulant found in cigarettes, shoots up anxiety, so quitting smoking has a noticeable contraction in anxiety symptoms and supports better mental health. The study “Smoking cessation is associated with lower rates of mood/anxiety and alcohol use disorder” by Cavazos-Rehg, Patricia A., et al. (2014), uncovered that smokers with a history of mood or anxiety disorders who quit smoking had a 40% lower chance of experiencing recurrent or persistent mood and anxiety disorders over three years.
• Reduce Caffeine Intake: Reducing caffeine intake is essential for managing anxiety disorder, as it involves limiting beverages such as coffee, tea, and energy drinks. Caffeine escalates heart rate and induces feelings of concernment, both of which mimic and inflame anxiety symptoms, making its removal a good strategy for better anxiety control. 

A meta-analysis conducted by Liu, Chen, et al. (2024) in “Caffeine Intake and Anxiety: A Meta-Analysis” demonstrated a substantial association between caffeine consumption and increased risk of anxiety, with a standardized mean difference (SMD) of 0.94 indicating a notable correlation. The analysis revealed that low-dose caffeine intake was moderately linked with high anxiety risk (SMD = 0.61), while high doses were connected to a much stronger correlation with anxiety symptoms (SMD = 2.86). Contextually, standardized mean difference (SMD) is a statistical measure used to quantify the effect size or strength of the relation between caffeine uptake and anxiety.

• Implementation of Stress Management: Stress management in the context of treating anxiety disorders involves integrating techniques and strategies designed to help individuals manage and reduce stress, which magnifies anxiety symptoms. This approach is implemented as part of a comprehensive treatment plan and aims to address both the physiological and psychological aspects of stress that contribute to anxiety. Techniques  include relaxation exercises, mindfulness, cognitive-behavioral strategies, and lifestyle changes, all aimed at improving overall stress resilience and reducing the impact of stress on anxiety levels. Treatment plans for anxiety disorder enhance therapeutic outcomes and support individuals in achieving better control over their anxiety symptoms.By incorporating stress management. A study by Sharma, Manoj, et al. (2014) in “Mindfulness-Based Stress Reduction as a Stress Management Intervention for Healthy Individuals: A Systematic Review, “ found that participants in an 8-week MBSR program experienced a 35% reduction in distress and a 30% reduction in rumination related to anxiety symptoms (P = .016 and P = .010, respectively).
• Practice Relaxation Techniques: Practicing relaxation techniques, such as deep breathing, progressive muscle relaxation, and yoga, is vital for those with anxiety disorder. These techniques calm both mind and body, assuaging the physical symptoms of anxiety and fostering a sense of calmness and control. 

In the study “Effectiveness of relaxation techniques as an active ingredient of psychological interventions to reduce distress, anxiety, and depression in adolescents: a systematic review and meta-analysis” by Hamdani, Syed, Usman, et al. (2022), relaxation techniques were applied over an average of 22.27 sessions (± 12.48) across 9.55 weeks (± 2.92), with each session lasting approximately 66.5 minutes (± 32.32). The numbers in parentheses show the variability in the data; for example, the number of sessions varied by about 12 sessions, and the session length differed by about 32 minutes.  This structured and consistent approach magnifies the efficacy of the interventions.

• Engage in Physical Exercise: Physical exercise regulates anxiety disorder, as it inserts regular activities like walking, jogging, or strength training. Exercise triggers the release of endorphins, which reinforces a better mood and dampens stress, making it a powerful method for governing anxiety. The World Health Organization (2024) highlights in “Physical Activity: Key Facts” that regular physical activity can lower the risk of developing depression and anxiety disorders by 25-50%. It underscores the importance of consistent physical activity in promoting long-term mental health benefits.
• Maintain a Healthy Diet: Maintaining a healthy diet is associated with consuming a balanced intake of nutrients, covering fruits, vegetables, lean proteins, and whole grains. A nutritious diet supports brain function and health to remediate anxiety effects. A prospective cohort study, “Food, Mood, and Brain Health: Implications for the Modern Clinician” by Lachance, Laura, and Ramsey, Drew (2015), examining over 10,000 university students, found that those who closely adhered to a Mediterranean diet had a 42% reduced risk of developing depression over a follow-up period of 4.4 years. This dietary pattern is rich in fruits, vegetables, whole grains, and healthy fats, especially from fish and olive oil.

Therapies

Therapies are structured treatments designed to address mental health issues by providing tools and strategies to manage symptoms and improve well-being. The most common therapies used in managing anxiety disorder are given below as written by Smith, Anna (2020) in the MedicalNewsToday article, “14 types of therapy”:

• Cognitive Behavioral Therapy (CBT): Cognitive behavioral therapy serves as a structured psychological intervention targeting the negative thought patterns and behaviors specific to anxiety disorders. CBT transforms these maladaptive patterns into healthier responses, thereby mollifying the intensity and frequency of anxiety symptoms. 

Randomized placebo-controlled trials conducted by Otte, Christian (2011) in “Cognitive Behavioral Therapy in Anxiety Disorders: Current State of the Evidence,” showed that the effect size for CBT compared to placebo was 0.35 for panic disorder, 0.73 for generalized anxiety disorder, 0.68 for social anxiety disorder, and 0.73 for obsessive-compulsive disorder, indicating medium to large effects. The numbers mentioned refer to effect sizes, which measure how strong the impact of Cognitive Behavioral Therapy (CBT) is compared to a placebo. An effect size of 0.35 for panic disorder indicates a small to medium impact. Contrastingly, 0.73 for generalized anxiety disorder (GAD), social anxiety disorder, and obsessive-compulsive disorder (OCD) suggest a medium to large impact, meaning CBT is quite effective for these conditions.

• Meditation: Meditation functions as a complementary practice within anxiety disorder management, focusing on mindfulness and relaxation techniques. Meditation aids in depreciating the physiological arousal and stress that are hallmarks of anxiety, thereby promoting emotional stability by cultivating a zen-like mental state. 

A randomized controlled trial by Hoge, Elizabeth A., et al. (2013), “Randomized Controlled Trial of Mindfulness Meditation for Generalized Anxiety Disorder: Effects on Anxiety and Stress Reactivity,” covering 93 individuals with Generalized Anxiety Disorder (GAD), found that participants who completed an 8-week Mindfulness-Based Stress Reduction (MBSR) program experienced tremendous reductions in anxiety symptoms. The study showed a notable decrease in anxiety levels, as measured by the Clinical Global Impression of Severity (CGI-S) and the Beck Anxiety Inventory (BAI), with all comparisons yielding p-values of less than 0.05, indicating statistical significance.

• Psychotherapy: Psychotherapy operates as a comprehensive therapeutic approach where individuals with anxiety disorders engage in dialogue with a trained therapist. This form of treatment is instrumental in uncovering the underlying psychological factors contributing to anxiety, facilitating the maturation of potent coping mechanisms and long-term emotional resilience. The Anxiety and Depression Association of America (2022) reports that approximately 40 million people in the United States suffer from an anxiety disorder. Despite this, only 36.9% of those affected receive treatment.

Medications

Medications are prescribed drugs used to manage the symptoms of anxiety disorders by altering brain chemistry and allaying emotional and physical discomfort. The medicines used to treat anxiety disorders are SSRIs, anxiolytics, antidepressants, benzodiazepines, sedatives, and nerve pain medication. The most common medications for treating anxiety disorder are listed below as mentioned by Garakani, Amir, et al.’s research (2020) in “Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options”:

• SSRIs: Selective Serotonin Reuptake Inhibitors (SSRIs) are a type of antidepressant that raises serotonin levels in the brain. SSRIs are frequently utilized for anxiety disorders as they uplift mood, diminish anxiety symptoms, and contribute to emotional stability. Common SSRI medications used for anxiety include Sertraline (Zoloft), Fluoxetine (Prozac), Paroxetine (Paxil), and Escitalopram (Lexapro). In the study “Psychopharmacology of Anxiety Disorders” by Cassano, Giovanni B., et al. (2002), about 50% of patients treated with SSRIs experience a 25-35% reduction in anxiety symptoms, as measured by standardized scales. This degree of improvement is considered clinically vital with ramifications in better daily functioning.
• Anxiolytic: Anxiolytics are drugs specifically designed to subside anxiety by calming the nervous system. Anxiolytics manage acute anxiety symptoms, offering swift relief from amplified feelings of worry and apprehension. Simone, Christopher G., and Bobrin, Bradford D. (2023) in the book “Anxiolytics and Sedative-Hypnotics Toxicity” estimate that the prevalence of anxiolytic and sedative use disorder in the USA is 0.16% of the total population and 6% among individuals with concurrent illicit drug use disorder.
• Antidepressants: Antidepressants are medications that treat depression and anxiety by regulating neurotransmitter function in the brain. Antidepressants shrink anxiety symptoms, hoist mood, and empower emotional equilibrium, making them a prime option for treating anxiety disorders. 

A meta-analysis by Cipriani, Andrea, et al. (2018), published in The Lancet as “Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults with Major Depressive Disorder: A Systematic Review and Network Meta-Analysis,” revealed that antidepressants had a pooled effect size of 0.69 compared to placebo for treating anxiety disorders, establishing a moderate to large treatment effect.

• Benzodiazepines: Benzodiazepines are sedative medications that upsurge the effects of the neurotransmitter GABA, producing a tranquilizing effect. Benzodiazepines are used to address extreme anxiety by quickly easing symptoms, though they are prescribed for short-term use due to the risk of dependence. However, Buspirone, an anti-anxiety medication works differently from benzodiazepines and treats generalized anxiety disorder. 

Benzodiazepines alleviate anxiety symptoms compared to a placebo massively. A systematic review by Tibrewal, Prashant, et al. (2021) in “Benzodiazepines for the Long-Term Treatment of Anxiety Disorders?” announced a mean difference favoring benzodiazepines for generalized anxiety disorder (GAD) of −2.29 on the Hamilton Anxiety Scale, with a 95% credible interval ranging from −3.19 to −1.39. The Hamilton Anxiety Scale measures anxiety severity, with higher scores reflecting more severe symptoms. A mean difference of −2.29 implies that patients receiving benzodiazepines experienced a 2.29-point greater reduction in their anxiety scores compared to those receiving a placebo.

The 95% credible interval of −3.19 to −1.39 provides a range within which the true effect size will likely fall with 95% certainty. This interval expresses that the reduction in anxiety symptoms due to benzodiazepines is statistically critical and supports the effectiveness of these medications in treating generalized anxiety disorder (GAD).

• Sedative: Sedatives are medications that stimulate relaxation and sleep by depressing central nervous system states. Sedatives assist in managing anxiety by bringing down tension and facilitating rest, especially when anxiety interrupts sleep. 

The review research article “Does Acute Treatment with Sedatives/Hypnotics for Anxiety in Depressed Patients Affect Suicide Risk? A Literature Review” by Youseff and Rich (2008) examined whether sedative/hypnotic medications, including benzodiazepines, reduce suicide risk when used early in the treatment of anxious depressed patients. The findings indicate that there is no evidence suggesting these medications decrease suicide risk, although they can have depressant and disinhibitory effects that may potentially increase risk. Despite the lack of clear evidence connecting the brief early use of these drugs to increased suicide risk, the authors caution against their use and recommend exploring alternative treatments for managing anxiety in patients with depression and suicidal tendencies.

• Nerve Pain Medication: Nerve pain medications, such as certain anticonvulsants, are used off-label to treat anxiety by stabilizing nerve impulses. These medications assuage anxiety symptoms by soothing overactive nerves and placating associated physical agitations. 

The study “Depression Prevalence in Neuropathic Pain and Its Impact on the Quality of Life” by Cherif, Farah, et al. (2020) explores the connection between depression, neuropathic pain (NP), and quality of life in 61 patients. It discovered that 65.6% of participants experienced depression and 73.7% had anxiety. The quality of life was impaired, as evidenced by low scores on the SF-12, a tool that assesses physical and mental health quality, and high scores on the Brief Pain Inventory (BPI), which measures pain severity and interference. The study also presented that higher levels of depression were associated with more intense pain, accentuating the need for routine depression screening in the management of neuropathic pain because it influences patients’ all-inclusive well-being.

What Are the Key Risk Factors for Anxiety Disorders?

The common risk factors of anxiety disorders include genetic predisposition, stressful life events, personality traits, and chronic health conditions. The most common risk factors are given below according to Morris-Rosendahl, Deborah J. (2002) in “Are there anxious genes?”

• Genetic predisposition: Anxiety disorders run in families, indicating a hereditary component that increases susceptibility. A family history of mental health conditions can heighten the likelihood of developing anxiety. Twin and family studies suggest a significant genetic component in GAD, with heritability estimated at around 30%. However, research by Kendler et al. (1992) revealed that the genetic factors linked to GAD are entirely shared with depression, while the environmental influences appear to be unique to GAD. 

Twin studies conducted by Hettema et al. (2001) in “A Review and Meta-Analysis of the Genetic Epidemiology of Anxiety Disorders” suggest that 30% to 40% of the variance in vulnerability to panic disorder (PD) is attributable to genetic factors. The remaining variance is due to individual-specific environmental and life experiences not shared with others.

• Stressful life events: Traumatic experiences, such as abuse, loss of a loved one, or significant life transitions, act as triggers for anxiety. Repeated exposure to stress or sudden overwhelming events intensifies anxiety symptoms. According to the Stress Statistics UK (2023) survey, 61% of adults who reported feeling stressed also experienced anxiety. Furthermore, 51% of those stressed individuals also reported symptoms of depression.
• Personality traits: Individuals with certain personality traits, like high levels of shyness or a tendency to overthink, are more prone to anxiety. Those with low self-esteem or perfectionistic tendencies are also at higher risk. Studies show that individuals with high neuroticism scores are more likely to experience anxiety disorders. For instance, one study “The Role of Neuroticism and Extraversion in the Stress-Anxiety and Stress-Depression Relationships,” by Uliaszek, Amanda A., et al. (2010) indicated that neuroticism accounted for 85.5% of the variance in the relationship between depression and interpersonal anxiety symptoms in males and 37.1% in females.
• Chronic health conditions: Physical conditions such as heart disease, diabetes, or chronic pain disorders lead to sustained anxiety. The ongoing struggle with a long-term illness exacerbates worry and stress, fueling anxiety symptoms. A study “Prevalence and correlates of stress, anxiety, and depression in patients with chronic diseases: a cross-sectional study, “ by Swathi M., et al. (2023) reported that 51.1% of patients with chronic diseases experienced anxiety. This highlights the significant mental health burden among individuals with chronic illnesses.

How Common are Anxiety Disorders?

Anxiety disorders are common in that they affect 19.1% of adults in the United States annually, according to the National Alliance on Mental Health (2017). Women are more likely to experience anxiety disorders, with a prevalence of 23.4% compared to 14.3% in men. The World Health Organization (2023) reports that anxiety disorders impact 301 million people globally, with an estimated 58 million new cases each year.

What Are the Types of Anxiety Disorders?

The types of anxiety disorders are Generalized Anxiety Disorder (GAD), panic disorder, social anxiety disorder (Social Phobia), specific phobias, Separation Anxiety Disorder (SAD), Medication-Induced Anxiety Disorder, and unspecified anxiety disorder. The most common types of anxiety disorders are listed below as determined by Cleveland Clinic’s (2024) article “Overview: What is an anxiety disorder”:

• Generalized Anxiety Disorder (GAD): Generalized Anxiety Disorder is an enduring condition depicted by pervasive and excessive worry about diverse elements of life, occasioning consistent push-and-pull, restlessness, and difficulties in concentration. This ongoing anxiety discombobulates workaday activities and massively impairs comprehensive functioning.
• Panic Disorder: Panic Disorder is marked by recurrent and unpredictable panic attacks, which are sudden episodes of extreme fear accompanied by physical symptoms such as rapid heartbeat, sweating, and shortness of breath. This disorder blossoms into an incessant fear of future attacks and escapism of scenarios where attacks possibly eventuate.
• Social Anxiety Disorder (Social Phobia): Social Anxiety Disorder, also referred to as social phobia, is denoted by an overbearing fear of social situations where there is a possibility for scrutiny. This fear nurtures avoidance behaviors and afflictions in social interactions, impacting relationships and professional existence.
• Specific Phobias: Specific phobias involve an intense and irrational fear of certain objects or situations, such as spiders, heights, or flying. This fear is disproportionate to the actual threat and leads to evasive behaviors that preclude functioning.
• Obsessive-Compulsive Disorder: Obsessive-compulsive disorder (OCD) is a mental health condition characterized by persistent, intrusive thoughts (obsessions) and repetitive behaviors or mental acts (compulsions) performed to alleviate the distress caused by these thoughts. The disorder significantly impacts daily functioning and can cause considerable distress and impairment.
• Separation Anxiety Disorder (SAD): Separation Anxiety Disorder is characterized by excessive fear or anxiety about being separated from attachment figures or familiar surroundings. This disorder results in extreme agony during or in anticipation of separation, disrupting social, academic, or occupational operations.
• Medication-Induced Anxiety Disorder: Medication-Induced Anxiety Disorder is when anxiety symptoms are directly triggered by the use or withdrawal of particular medications. These symptoms arise due to the medication’s effect on brain chemistry, causing anxiety that is closely tied to the medication’s presence or absence.
• Unspecified Anxiety Disorder: Unspecified Anxiety Disorder is diagnosed when anxiety symptoms induce anguish or impairment but do not fully align with the criteria for any specific anxiety disorder. This category allows for the treatment of anxiety symptoms that do not fit neatly into other diagnostic categories.

Can Anxiety Disorder Cause Depression?

Yes, anxiety disorder can cause depression. Kalin, Ned H. (2020) in the research “The Critical Relationship Between Anxiety and Depression” published in the American Journal of Psychiatry, notes that an estimated 60% of people with anxiety disorders also have symptoms of depression. 

In a study by Chodavadia, Parth, et al. (2023), titled “Prevalence and economic burden of depression and anxiety symptoms among Singaporean adults: results from a 2022 web panel,” 2,348 respondents completed the PHQ-4 depression/anxiety screener on behalf of the 5,725 adults in their households, inclusive of themselves. 

Among these adults, 14.1% divulged to have symptoms consistent with depression, and 15.2% with anxiety. The study found that 66.0% of those with depression also had anxiety symptoms, and 61.0% of those with anxiety had symptoms of depression. Generally, 20.0% of adults had at least one of these conditions, yet about half of them (53.6% for anxiety and 49.1% for depression) had never been formally diagnosed. The presence of both conditions sets up more grave symptoms and complicates treatment outcomes.

How Do Neurotransmitters Affect Anxiety?

Neurotransmitters like serotonin, gamma-aminobutyric acid (GABA), and norepinephrine directly affect anxiety by regulating mood, stress responses, and relaxation. Research by Martin, Elizabeth I., et al. (2009) in “The Neurobiology of Anxiety Disorders: Brain Imaging, Genetics, and Psychoneuroendocrinology” indicates that patients with anxiety disorders exhibit increased glutamate activity, which is associated with symptom severity. The study found that individuals with social anxiety disorder had a 13.2% higher glutamate-to-creatine ratio in the anterior cingulate cortex compared to controls, suggesting a potential causal role in anxiety symptoms.

Can You Get Rid of Anxiety Disorder?

Yes, you can get rid of anxiety disorder. However, it will take effort and the right diagnosis and treatment regimen because according to Garakani et al. (2020) in “Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options,” only 60–85% of patients with anxiety disorders experience at least a 50% improvement with existing biological and psychological treatments. Moreover, approximately 50% of these responders achieve full recovery, defined as minimal anxiety symptoms. Anxiety disorders, particularly generalized anxiety disorder (GAD) and social anxiety disorder (SAD), involve high rates of recurrence and persistent symptoms, especially in those with comorbid major depressive disorder (MDD). Factors such as misdiagnosis, poor treatment adherence, substance use, and other comorbidities may contribute to the refractory nature of these disorders, suggesting a need for alternative pharmacotherapies. Nevertheless, many current investigational treatments are merely modifications of existing therapies.

Who Are the Specialists for Anxiety Disorder?

The specialists for diagnosing and treating anxiety disorders are clinical psychologists, psychiatrists, and primary care providers. Clinical psychologists particularize in diagnosing and treating anxiety disorders through therapeutic approaches like cognitive-behavioral therapy. As proscribed by Hoffman, Stefan G., et al. (2012) in the research “The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-analyses,” about 60-80% of patients benefit from CBT, making psychologists paramount in treating anxiety disorder. Psychiatrists are medical doctors with specialized training in mental health diagnose anxiety disorders and prescribe medications when necessary. Primary Care Providers (PCPs) are the first point of contact for individuals going through anxiety symptoms, they conduct initial assessments and refer patients to mental health specialists when appropriate.